A review on CRISPR-Cas system based applications in Oncology
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Egile nagusia: | Sadia, Mir |
---|---|
Beste egile batzuk: | Sayka Khan, Tanisha Tabassum |
Formatua: | Thesis |
Hizkuntza: | en_US |
Argitaratua: |
Brac University
2022
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/17517 |
Antzeko izenburuak
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
nork: Maria, Amatul
Argitaratua: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
nork: Shaikat, Mahdi Mubin
Argitaratua: (2023) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
nork: Nwabunwanne, Eze Uchenna
Argitaratua: (2022) -
A review on CRISPR Technology as an Antiviral Tool
nork: Srishti, Sanjida Ahmed
Argitaratua: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
nork: Eva, Israt Ara Jannat
Argitaratua: (2023)